Decriminalization or more treatment? Comparing 2 approaches to the drug overdose crisis.
作者信息
Caswell Charlotte, Krausz R Michael, Leyton Marco
机构信息
From the Integrated Program in Neuroscience, McGill University, Montréal, Que. (Caswell); Faculty of Medicine, University of British Columbia, Vancouver, BC (Krausz); Departments of Psychiatry, Psychology, and Neurology and Neurosurgery, McGill University, Montréal, Que. (Leyton); Center for Studies in Behavioural Neurobiology, Concordia University (Leyton); Research Unit on Children's Psychosocial Maladjustment, Université de Montréal, Montréal, Que. (Leyton).
出版信息
J Psychiatry Neurosci. 2025 Jun 20;50(3):E197. doi: 10.1503/jpn.250084. Print 2025 May-Jun.
Abstract
摘要
相似文献
1
Decriminalization or more treatment? Comparing 2 approaches to the drug overdose crisis.
J Psychiatry Neurosci. 2025 Jun 20;50(3):E197. doi: 10.1503/jpn.250084. Print 2025 May-Jun.
2
People who use drugs' prioritization of regulation amid decriminalization reforms in British Columbia, Canada: A qualitative study.
Int J Drug Policy. 2024 Mar;125:104354. doi: 10.1016/j.drugpo.2024.104354. Epub 2024 Feb 24.
3
Safer Opioid Supply, Subsequent Drug Decriminalization, and Opioid Overdoses.
JAMA Health Forum. 2025 Mar 7;6(3):e250101. doi: 10.1001/jamahealthforum.2025.0101.
4
The impact of the novel coronavirus disease (COVID-19) pandemic on drug overdose-related deaths in the United States and Canada: a systematic review of observational studies and analysis of public health surveillance data.
Subst Abuse Treat Prev Policy. 2021 Nov 29;16(1):87. doi: 10.1186/s13011-021-00423-5.
5
'Drug decriminalization' in Canada: a plea for a nuanced, evidence-informed, and realistic approach towards improved health outcomes.
Can J Public Health. 2023 Dec;114(6):943-946. doi: 10.17269/s41997-023-00809-x. Epub 2023 Jul 18.
6
Experiences of stigmatization among people who use drugs in the initial year of British Columbia's drug decriminalization policy: A qualitative study.
Int J Drug Policy. 2025 May;139:104791. doi: 10.1016/j.drugpo.2025.104791. Epub 2025 Apr 5.
7
Decriminalization or police mission creep? Critical appraisal of law enforcement involvement in British Columbia, Canada's decriminalization framework.
Int J Drug Policy. 2024 Jul;129:104478. doi: 10.1016/j.drugpo.2024.104478. Epub 2024 Jun 15.
8
"There are solutions and I think we're still working in the problem": The limitations of decriminalization under the good Samaritan drug overdose act and lessons from an evaluation in British Columbia, Canada.
Int J Drug Policy. 2022 Jul;105:103714. doi: 10.1016/j.drugpo.2022.103714. Epub 2022 May 10.
9
Understanding the rise in overdose deaths involving opioids and non-opioid prescription drugs in the United States.
Int J Drug Policy. 2023 Jul 6:104104. doi: 10.1016/j.drugpo.2023.104104.
10
Does drug decriminalization increase unintentional drug overdose deaths?: Early evidence from Oregon Measure 110.
J Health Econ. 2023 Sep;91:102798. doi: 10.1016/j.jhealeco.2023.102798. Epub 2023 Jul 28.
本文引用的文献
1
Drug Decriminalization in British Columbia and Changes in Drug Crime and Opioid and Stimulant Harms.
JAMA. 2025 Jun 3;333(21):1922-1925. doi: 10.1001/jama.2025.3006.
2
Lessons Learned From Drug Decriminalization Remedies in British Columbia.
JAMA Psychiatry. 2025 Jul 1;82(7):640-642. doi: 10.1001/jamapsychiatry.2025.1006.
3
Ending the overdose epidemic by ending the war on drug users: Can this work?
J Psychiatry Neurosci. 2024 Feb 21;49(1):E77-E80. doi: 10.1503/jpn.240003. Print 2024 Jan-Feb.
4
British Columbia's Safer Opioid Supply Policy and Opioid Outcomes.
JAMA Intern Med. 2024 Mar 1;184(3):256-264. doi: 10.1001/jamainternmed.2023.7570.
5
Effect of Risk Mitigation Guidance opioid and stimulant dispensations on mortality and acute care visits during dual public health emergencies: retrospective cohort study.
BMJ. 2024 Jan 10;384:e076336. doi: 10.1136/bmj-2023-076336.
Zotero 插件